Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.

Bibliographic Details
Main Authors:	Pellagatti, A, Esoof, N, Watkins, F, Langford, C, Vetrie, D, Campbell, L, Fidler, C, Cavenagh, J, Eagleton, H, Pushkaran, B, Kwan, M, Wainscoat, J, Boultwood, J
Format:	Conference item
Published:	2003

Similar Items

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.
by: Pellagatti, A, et al.
Published: (2004)

Gene expression profiling in the myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2005)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
by: Pellagatti, A, et al.
Published: (2004)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1995)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
by: Pellagatti, A, et al.
Published: (2005)

Clonality in the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2001)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
by: Fidler, C, et al.
Published: (2004)

Molecular pathogenesis of the myelodysplastic syndromes
by: Boultwood, J, et al.
Published: (1999)

Gene expression profiling in polycythemia vera using cDNA microarray technology.
by: Pellagatti, A, et al.
Published: (2003)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
by: Pellagatti, A, et al.
Published: (2008)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
by: Zhang, J, et al.
Published: (2004)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
by: Pellagatti, A, et al.
Published: (2006)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1997)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Advances in the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2010)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2007)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
by: Pellagatti, A, et al.
Published: (2010)

The 5q-syndrome.
by: Boultwood, J, et al.
Published: (1994)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2009)

SF3B1 mutant myelodysplastic syndrome: Recent advances
by: Pellagatti, A, et al.
Published: (2020)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
by: Pellagatti, A, et al.
Published: (2006)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
by: Boultwood, J, et al.
Published: (1991)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2014)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
by: Pellagatti, A, et al.
Published: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
by: Pellagatti, A, et al.
Published: (2011)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
by: Pellagatti, A, et al.
Published: (2007)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
by: Jadersten, M, et al.
Published: (2005)

The 5q- syndrome.
by: Giagounidis, A, et al.
Published: (2004)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
by: Lewis, S, et al.
Published: (1995)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
by: Pellagatti, A, et al.
Published: (2016)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2009)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
by: Fidler, C, et al.
Published: (1999)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
by: Boultwood, J, et al.
Published: (2000)